Skip to main content
OpenTrials

Clinical trial condition

MDS

Explore clinical trials studying MDS. Study availability and eligibility vary by location and protocol.

105 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

MDS trial results

Active, not recruiting

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

NCT04730258

Conditions
AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +19 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Norton Cancer Institute - Saint Matthews Louisville, Kentucky, United States
  • New York Presbyterian Weill Cornell Medical Center New York, United States
View Trial Details
Active, not recruiting

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

NCT04623944

Conditions
AML, Adult, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

NCT00863148

Conditions
ALL, AML, BAL, +1 more
Locations
  • Hôpital Edouard Herriot Lyon, France
  • Institut Paoli Calmettes Marseille, France
  • Nantes University hospital Nantes, France
  • Hôpital Saint Louis Paris, France
View Trial Details
Completed

A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)

NCT05829226

Conditions
AML, Adult Recurrent, Disease Attributes, Hematologic Diseases, +10 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • Baptist Health South Florida-Miami Cancer Institute Miami, Florida, United States
  • Norton Healthcare-Norton Cancer Institute Louisville, Kentucky, United States
View Trial Details
Completed

Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT

NCT02872662

Conditions
MDS, MRD, SCT
Locations
  • Department of Hematology, Aarhus University Hospital Aarhus, Denmark
  • Department of Hematology, Rigshospitalet Univsersity Hospital Copenhagen, Denmark
  • Department of Medcine, Haukeland University Hospital Bergen, Norway
  • Department of Hematology, Rikshospitalet University Hospital Oslo, Norway
View Trial Details
Completed

ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients

NCT04857645

Conditions
AML, MDS
Locations
  • CHU d'Amiens Picardie - Site sud - Service hématologie clinique et thérapie cellulaire Amiens, France
  • CHU d'Angers - Service des maladies du sang Angers, France
  • CHU Estaing - Service hématologie clinique et thérapie cellulaire Clermont-Ferrand, France
  • CHU de Grenoble - Clinique Universitaire d'hématologie Grenoble, France
View Trial Details

Related conditions